PMID- 25702278 OWN - NLM STAT- MEDLINE DCOM- 20150519 LR - 20220408 IS - 1879-1913 (Electronic) IS - 0002-9149 (Print) IS - 0002-9149 (Linking) VI - 115 IP - 7 DP - 2015 Apr 1 TI - Dystrophin genotype-cardiac phenotype correlations in Duchenne and Becker muscular dystrophies using cardiac magnetic resonance imaging. PG - 967-71 LID - S0002-9149(15)00065-X [pii] LID - 10.1016/j.amjcard.2015.01.030 [doi] AB - Duchenne and Becker muscular dystrophies are caused by mutations in dystrophin. Cardiac manifestations vary broadly, making prognosis difficult. Current dystrophin genotype-cardiac phenotype correlations are limited. For skeletal muscle, the reading-frame rule suggests in-frame mutations tend to yield milder phenotypes. We performed dystrophin genotype-cardiac phenotype correlations using a protein-effect model and cardiac magnetic resonance imaging. A translational model was applied to patient-specific deletion, indel, and nonsense mutations to predict exons and protein domains present within truncated dystrophin protein. Patients were dichotomized into predicted present and predicted absent groups for exons and protein domains of interest. Development of myocardial fibrosis (represented by late gadolinium enhancement [LGE]) and depressed left ventricular ejection fraction (LVEF) were compared. Patients (n = 274) with predicted present cysteine-rich domain (CRD), C-terminal domain (CTD), and both the N-terminal actin-binding and cysteine-rich domains (ABD1 + CRD) had a decreased risk of LGE and trended toward greater freedom from LGE. Patients with predicted present CTD (exactly the same as those with in-frame mutations) and ABD1 + CRD trended toward decreased risk of and greater freedom from depressed LVEF. In conclusion, genotypes previously implicated in altering the dystrophinopathic cardiac phenotype were not significantly related to LGE and depressed LVEF. Patients with predicted present CRD, CTD/in-frame mutations, and ABD1 + CRD trended toward milder cardiac phenotypes, suggesting that the reading-frame rule may be applicable to the cardiac phenotype. Genotype-phenotype correlations may help predict the cardiac phenotype for dystrophinopathic patients and guide future therapies. CI - Copyright (c) 2015 Elsevier Inc. All rights reserved. FAU - Tandon, Animesh AU - Tandon A AD - The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. FAU - Jefferies, John L AU - Jefferies JL AD - The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. FAU - Villa, Chet R AU - Villa CR AD - The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. FAU - Hor, Kan N AU - Hor KN AD - The Heart Center, Nationwide Children's Hospital, Columbus, Ohio. FAU - Wong, Brenda L AU - Wong BL AD - Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. FAU - Ware, Stephanie M AU - Ware SM AD - The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. FAU - Gao, Zhiqian AU - Gao Z AD - The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. FAU - Towbin, Jeffrey A AU - Towbin JA AD - The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. FAU - Mazur, Wojciech AU - Mazur W AD - The Heart and Vascular Center at the Christ Hospital, Cincinnati, Ohio. FAU - Fleck, Robert J AU - Fleck RJ AD - Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. FAU - Sticka, Joshua J AU - Sticka JJ AD - The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. FAU - Benson, D Woodrow AU - Benson DW AD - Herma Heart Center, Children's Hospital of Wisconsin, Milwaukee, Wisconsin. FAU - Taylor, Michael D AU - Taylor MD AD - The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Electronic address: Michael.Taylor1@cchmc.org. LA - eng GR - UL1 RR026314/RR/NCRR NIH HHS/United States GR - UL1 TR000077/TR/NCATS NIH HHS/United States GR - UL1 TR001425/TR/NCATS NIH HHS/United States PT - Journal Article DEP - 20150115 PL - United States TA - Am J Cardiol JT - The American journal of cardiology JID - 0207277 RN - 0 (Dystrophin) RN - 9007-49-2 (DNA) SB - IM MH - Adolescent MH - Adult MH - Cardiomyopathies/*diagnosis/etiology/genetics MH - Child MH - Child, Preschool MH - DNA/*genetics MH - DNA Mutational Analysis MH - Dystrophin/*genetics/metabolism MH - Exons MH - Female MH - Humans MH - Magnetic Resonance Imaging MH - Magnetic Resonance Imaging, Cine/*methods MH - Male MH - Muscle, Skeletal/*metabolism MH - Muscular Dystrophy, Duchenne/complications/*genetics/metabolism MH - *Mutation MH - Sequence Deletion MH - Young Adult PMC - PMC5568575 MID - NIHMS896074 COIS- Disclosures The authors have no conflicts of interest to disclose. EDAT- 2015/02/24 06:00 MHDA- 2015/05/20 06:00 PMCR- 2017/08/23 CRDT- 2015/02/23 06:00 PHST- 2014/10/20 00:00 [received] PHST- 2015/01/06 00:00 [revised] PHST- 2015/01/06 00:00 [accepted] PHST- 2015/02/23 06:00 [entrez] PHST- 2015/02/24 06:00 [pubmed] PHST- 2015/05/20 06:00 [medline] PHST- 2017/08/23 00:00 [pmc-release] AID - S0002-9149(15)00065-X [pii] AID - 10.1016/j.amjcard.2015.01.030 [doi] PST - ppublish SO - Am J Cardiol. 2015 Apr 1;115(7):967-71. doi: 10.1016/j.amjcard.2015.01.030. Epub 2015 Jan 15.